Reuters logo
BRIEF-Intra-Cellular Therapies reports Q2 loss per share $0.41
August 9, 2017 / 12:44 PM / in 4 months

BRIEF-Intra-Cellular Therapies reports Q2 loss per share $0.41

Aug 9 (Reuters) - Intra-cellular Therapies Inc

* Intra-Cellular Therapies reports second quarter 2017 financial results and provides corporate update

* Q2 loss per share $0.41

* Q2 earnings per share view $-0.74 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below